The NPs produced were used for siRNA delivery targeting sphingosine-1-phosphate receptor 1 (S1PR1) and the gene for glycoprotein 130 (GP130), both associated with suppression of the transcription of STAT3 and other signaling molecules associated with cancer progression. Here, S1PR1 is linked to cancer.